Gaze MN - Search Results

1

[131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter.

McCluskey AG, Boyd M, Ross SC, Cosimo E, Clark AM, Angerson WJ, Gaze MN, Mairs RJ. McCluskey AG, et al. Among authors: gaze mn. Clin Cancer Res. 2005 Nov 1;11(21):7929-37. doi: 10.1158/1078-0432.CCR-05-0982. Clin Cancer Res. 2005. PMID: 16278418

2

[131I]MIBG and topotecan: a rationale for combination therapy for neuroblastoma.

McCluskey AG, Boyd M, Gaze MN, Mairs RJ. McCluskey AG, et al. Among authors: gaze mn. Cancer Lett. 2005 Oct 18;228(1-2):221-7. doi: 10.1016/j.canlet.2004.11.062. Cancer Lett. 2005. PMID: 15935554 Review.

3

Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter.

McCluskey AG, Mairs RJ, Tesson M, Pimlott SL, Babich JW, Gaze MN, Champion S, Boyd M. McCluskey AG, et al. Among authors: gaze mn. J Nucl Med. 2012 Jul;53(7):1146-54. doi: 10.2967/jnumed.111.095943. Epub 2012 Jun 11. J Nucl Med. 2012. PMID: 22689924 Free article.

4

131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

Gaze MN, Mairs RJ, Boyack SM, Wheldon TE, Barrett A. Gaze MN, et al. Br J Cancer. 1992 Dec;66(6):1048-52. doi: 10.1038/bjc.1992.408. Br J Cancer. 1992. PMID: 1457344 Free PMC article.

5

Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction.

Mairs RJ, Livingstone A, Gaze MN, Wheldon TE, Barrett A. Mairs RJ, et al. Among authors: gaze mn. Br J Cancer. 1994 Jul;70(1):97-101. doi: 10.1038/bjc.1994.256. Br J Cancer. 1994. PMID: 7517173 Free PMC article.

6

Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.

Gaze MN, Hamilton TG, Mairs RJ. Gaze MN, et al. Br J Radiol. 1994 Jun;67(798):573-8. doi: 10.1259/0007-1285-67-798-573. Br J Radiol. 1994. PMID: 8032811

7

Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.

Armour A, Mairs RJ, Gaze MN, Wheldon TE. Armour A, et al. Among authors: gaze mn. Br J Cancer. 1994 Sep;70(3):445-8. doi: 10.1038/bjc.1994.325. Br J Cancer. 1994. PMID: 8080728 Free PMC article.

8

Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination.

McCluskey AG, Boyd M, Pimlott SL, Babich JW, Gaze MN, Mairs RJ. McCluskey AG, et al. Among authors: gaze mn. Br J Radiol. 2008 Oct;81 Spec No 1:S28-35. doi: 10.1259/bjr/27723093. Br J Radiol. 2008. PMID: 18819996

9

An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.

Nile DL, Rae C, Hyndman IJ, Gaze MN, Mairs RJ. Nile DL, et al. Among authors: gaze mn. BMC Cancer. 2016 Aug 11;16:621. doi: 10.1186/s12885-016-2656-8. BMC Cancer. 2016. PMID: 27515310 Free PMC article.

10

The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G.

Mairs RJ, Gaze MN, Barrett A. Mairs RJ, et al. Among authors: gaze mn. Br J Cancer. 1991 Aug;64(2):293-5. doi: 10.1038/bjc.1991.294. Br J Cancer. 1991. PMID: 1892758 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters